PMID: 8950008Nov 1, 1996Paper

Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity

Behavioural Brain Research
I WeinerJ Feldon

Abstract

Latent inhibition (LI) consists of retardation in conditioning to a stimulus as a consequence of its prior non-reinforced pre-exposure. In view of findings that LI is disrupted in acute schizophrenic patients and evidence from animal experiments pointing to the involvement of the mesolimbic dopamine (DA) system in this phenomenon, the present study investigated the effects of electrolytic lesions to the shell and core subterritories of the nucleus accumbens on LI in rats (Expt. 1). LI was indexed by the amount of suppression of drinking in the presence of a tone that was either pre-exposed or not prior to its pairing with reinforcement (a foot shock). Expt.2 tested the effects of the DA antagonist, haloperidol, on LI in shell- and core-lesioned animals. Expt. 3 tested the effects of shell and core lesions on spontaneous and amphetamine-induced locomotion. In Expt. 1, LI, i.e., lower suppression of drinking in the pre-exposed as compared to the non-pre-exposed animals, was obtained in the sham-operated condition. Core and shell lesions produced distinct effects on LI. Animals with core lesions developed LI, but exhibited an overall lower suppression of drinking in comparison to the sham-operated animals. In contrast, shell lesio...Continue Reading

References

Mar 15, 1978·The Journal of Comparative Neurology·J E Krettek, J L Price
Oct 15, 1978·European Journal of Pharmacology·D WirtshafterE W Kent
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleR S Frackowiak
Aug 1, 1990·The Journal of Comparative Neurology·H Kita, S T Kitai
Nov 1, 1990·Psychological Bulletin·I Weiner
Aug 1, 1988·Trends in Neurosciences·D R Weinberger
Oct 1, 1988·The Journal of Nervous and Mental Disease·I BaruchJ A Gray
Jan 1, 1987·Psychopharmacology·I Weiner, J Feldon
Aug 1, 1988·Pharmacology, Biochemistry, and Behavior·I WeinerJ Feldon
Apr 1, 1988·Biological Psychiatry·G W ChristisonC D Kilts
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Feb 1, 1987·Pharmacology, Biochemistry, and Behavior·I WeinerY Katz
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Jan 1, 1987·Schizophrenia Bulletin·R Anscombe
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·R D Oades
Aug 1, 1985·Archives of General Psychiatry·B BogertsR Schönfeldt-Bausch
Oct 1, 1985·Neuroscience·O T Phillipson, A C Griffiths
Aug 1, 1973·Archives of General Psychiatry·J R Stevens
Jun 1, 1973·Psychological Bulletin·R E Lubow
Dec 1, 1969·Journal of Comparative and Physiological Psychology·J E AckilG P Frommer
Mar 1, 1966·Brain : a Journal of Neurology·G RaismanT P Powell
Oct 1, 1982·Archives of General Psychiatry·J R Stevens

❮ Previous
Next ❯

Citations

Feb 5, 2000·European Journal of Pharmacology·C CadoniG Di Chiara
Nov 5, 1998·Pharmacology, Biochemistry, and Behavior·J E AbermanJ D Salamone
Sep 30, 2000·Brain Research. Brain Research Reviews·P C MoserP M Moran
Feb 13, 2001·Behavioural Brain Research·N A SchmajukJ A Gray
Dec 24, 1997·Behavioural Brain Research·I Weiner, J Feldon
May 10, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·David J GraceyDavid J King
Apr 20, 2011·Behavioral Neuroscience·Amy C ChessJohn T Green
Mar 20, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michal Arad, Ina Weiner
Mar 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francisca F Meyer, Alain Louilot
Feb 3, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Helen H J PothuizenJoram Feldon
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Patricia Di CianoBarry J Everitt
Jul 23, 1999·Annals of the New York Academy of Sciences·I WeinerJ Feldon
Jan 26, 2011·Journal of Psychopharmacology·A J D NelsonH J Cassaday

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.